Search

everythinglearnresearchcommunity

for

Search:↓

Stopping alpha-blocker medication after 6-9 months is safe and effective for most patients with bladder outlet obstruction.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Castration is preferred for non-breeding male dogs with BPH, but other treatments are available with specific pros and cons.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

Testosterone works in different ways, including direct interaction with its receptor, conversion to other hormones for specific effects on genitalia, hair, bones, and muscle, and changes in body fat and sexual function when low.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

Large prostate links to more hair loss, but age of onset doesn't affect it.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

No link found between hair loss severity and PSA levels in men.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

Higher DHT in male baldness may protect against prostate cancer.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Suppressing certain hormones might help prevent prostate cancer.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Early balding at 40 increases prostate cancer risk.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.